Detailed Information on Publication Record
2006
Gonadal protection with GnRH analogues during chemotherapy – cytotoxic dose derived cohort study (OVARONKO)
HUSER, Martin, Igor CRHA, Robert HUDEČEK, Pavel VENTRUBA, Jana ŽÁKOVÁ et. al.Basic information
Original name
Gonadal protection with GnRH analogues during chemotherapy – cytotoxic dose derived cohort study (OVARONKO)
Name in Czech
Gonadal protection with GnRH analogues during chemotherapy – cytotoxic dose derived cohort study (OVARONKO)
Name (in English)
Gonadal protection with GnRH analogues during chemotherapy – cytotoxic dose derived cohort study (OVARONKO)
Authors
HUSER, Martin (203 Czech Republic, guarantor), Igor CRHA (203 Czech Republic), Robert HUDEČEK (203 Czech Republic), Pavel VENTRUBA (203 Czech Republic), Jana ŽÁKOVÁ (203 Czech Republic), Lenka ŠMARDOVÁ (203 Czech Republic) and Zdeněk KRÁL (203 Czech Republic)
Edition
Gynecological Endocrinology, 2006, 0951-3590
Other information
Language
Czech
Type of outcome
Článek v odborném periodiku
Field of Study
30214 Obstetrics and gynaecology
Country of publisher
Czech Republic
Confidentiality degree
není předmětem státního či obchodního tajemství
Impact factor
Impact factor: 0.995
RIV identification code
RIV/00216224:14110/06:00018892
Organization unit
Faculty of Medicine
Keywords in English
fertility
Tags
Změněno: 2/4/2010 20:59, prof. MUDr. Martin Huser, Ph.D., MBA
V originále
Gonadal protection with GnRH analogues during chemotherapy – cytotoxic dose derived cohort study (OVARONKO).
In English
Gonadal protection with GnRH analogues during chemotherapy – cytotoxic dose derived cohort study (OVARONKO).
Links
| NR8469, research and development project |
|